Delivery Order SPE2DB22D2103-SPE2DB24FR9GN
Award Date 5/1/24
Potential Completion Date 5/22/24
Potential Value $26K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQBGX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The award, which has a ceiling value of $13,408.24, is a Firm Fixed Price Delivery Order with an ultimate completion date of January 17, 2025. This contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare...
- This federal contract award, identified as SPE2DB24D2205|SPE2DB25FDYXA, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $13,408.24, is a Firm Fixed Price Delivery Order for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime...
- This federal contract award, with ID SPE2DB24D1021|SPE2DB25FEVCE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $13,408.24, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB22FR83X, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,345.35 firm fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, with a period of performance through March 9, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical supplier of...
- This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX5HD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $77,761.80 and a completion date of December 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $58,042.02 and an ultimate completion date of December 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The $12,960.30 firm fixed price delivery order has an ultimate completion date of October 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary...
- This federal contract award, with an ID of SPE2DB20D3303|SPE2DB24FZ2C3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, a firm fixed price delivery order, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The award has a ceiling value of $37,036.02 and a period of performance through April 9, 2024. This contract is not designated as a set-aside....
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of the drug VYNDAMAX 61 MG CAPSULE UD 30S, with a ceiling value of $25,920.62 and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA8Q2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a performance period ending on March 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...